A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma

Grant

Date/time Interval

  • May 1, 2017 - April 30, 2020
  • Total Award Amount

  • 1604566.00
  • Direct Costs

  • 1158966.00
  • Sponsor Award Id

  • R01CA217179
  • Contributor

  • Anita Hjelmeland Ph.D.   Investigator  
  • Barton Guthrie M.D.   Investigator  
  • C. Ryan Miller   Investigator  
  • Caitlin Dalgo MSN, BSN, RN   Investigator  
  • Gary Cutter   Investigator  
  • George Gillespie   Investigator  
  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Inmaculada Aban   Investigator  
  • James Markert M.D., M.P.H.   Principal Investigator  
  • Jianmei Leavenworth Ph.D.   Investigator  
  • Kristen Riley   Investigator  
  • Lawrence Lamb Jr. Ph.D.   Investigator  
  • Louis Nabors M.D.   Investigator  
  • Mina Lobbous   Investigator  
  • Xiaosi Han   Investigator